These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2749889)

  • 41. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
    Golding H; Rittenberg MB
    J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G; Truitt RL; Johnson BD
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interferonogenic agent tilorone as a modulator of GvH reaction in mice.
    Zschiesche W; Slavina E; Leipunskaya I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):725-30. PubMed ID: 23088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction, specificity and elimination of asialo-GM1+ graft-versus-host effector cells of donor origin.
    Ghayur T; Xenocostas A; Seemayer TA; Lapp WS
    Scand J Immunol; 1991 Oct; 34(4):497-508. PubMed ID: 1833814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    Fowler DH; Kurasawa K; Husebekk A; Cohen PA; Gress RE
    J Immunol; 1994 Feb; 152(3):1004-13. PubMed ID: 7905495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective removal of T cell function from mouse lymphocyte suspensions by treatment with normal guinea pig serum.
    Kierszenbaum F; Budzko DB; Miller HC
    J Immunol; 1980 Apr; 124(4):1599-602. PubMed ID: 6988503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N; Radojcic V; Powell J; Luznik L
    Transplantation; 2007 Mar; 83(5):631-40. PubMed ID: 17353785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmentation of immune responses after methotrexate administration.
    Orbach-Arbouys S; Castes M
    Immunology; 1979 Feb; 36(2):265-9. PubMed ID: 35464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus.
    Korngold R; Blank KJ; Murasko DM
    J Immunol; 1983 May; 130(5):2236-40. PubMed ID: 6187846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of a glucocorticoid-sensitive F1-anti-parental mechanism that affects engraftment during graft-versus-host disease.
    You-Ten KE; Seemayer TA; Wisse B; Bertley FM; Lapp WS
    J Immunol; 1995 Jul; 155(1):172-80. PubMed ID: 7602093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
    Truitt RL; Rose WC; Rimm AA; Bortin MM
    Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal suppressor cells. Their influence on the cell-mediated immune responses.
    Ptak W; Skowron-Cendrzak S
    Transplantation; 1977 Jul; 24(1):45-51. PubMed ID: 18819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotropic activities of benzisoselenazolones and organic diselenides in mice.
    Błaszczyk B; Inglot AD; Kowalczyk-Bronisz SH; Szymaniec S; Młochowski J
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):305-11. PubMed ID: 8744651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on graft versus host (GvH) reactions. I. Impairment of hemopoietic stroma in mice suffering from GvH disease.
    Hirabayashi N
    Exp Hematol; 1981 Feb; 9(2):101-10. PubMed ID: 7238646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of Trichinella spiralis on graft-versus-host reaction, transplantation immunity and antibody formation.
    Chimyshkyan KL; Shvkvatsabaya IK; Ovumyan HS; Babichev VA; Trubcheninova LP; Sorokina EV; Svet-Moldavsky GJ
    Biomedicine; 1976 Jul; 25(5):176-80. PubMed ID: 11851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopathology of mouse hepatitis virus type 3mii. effect of immunosuppression in resistant mice.
    Dupuy JM; Levey-Leblond E; Le Prevost C
    J Immunol; 1975 Jan; 114(1 Pt 1):226-30. PubMed ID: 234497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study on the interaction of lymphotropic cytostatic agent treatment and graft-versus-host (GVH) reaction in mice.
    Anderlik P; Szeri I; Bános Z
    Ann Immunol Hung; 1975; 18():53-6. PubMed ID: 17349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.